World Bronchiectasis Day: American Lung Association Launches New Campaign to Support People Living with Chronic Lung Disease

WASHINGTON, July 1, 2025 /PRNewswire/ -- Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic and progressive lung condition that affects between 350,000 and 500,000 adults in the United States. The new campaign aims to educate people living with bronchiectasis about how to improve their disease management, help connect them with emotional support and ultimately improve their life.

Bronchiectasis is a chronic lung disease in which the airways (bronchi) become widened and scarred due to repeated inflammation and infection. This damage makes it difficult to clear mucus from the lungs, leading to persistent cough, shortness of breath, frequent infections and decreased lung function.

"While there is currently no cure for bronchiectasis, early diagnosis, effective management and a solid support system can help people with the disease lead heathy and active lives," said Harold Wimmer, President and CEO of the American Lung Association. "Through education, support and empowering individuals to communicate effectively with their healthcare providers, we can help patients better manage their symptoms and prevent serious complications."

The American Lung Association's free bronchiectasis awareness campaign includes:

• Patient education on managing flare-ups, understanding disease progression, and exploring treatment options.
• Resources for newly diagnosed patients to help navigate the condition from the start.
• Support for emotional wellbeing, including access to the Lung HelpLine and guidance on coping with the psychological impact of chronic lung disease.
• Patient stories and insights to amplify the voices of those living with bronchiectasis.
• Use of social listening to identify community needs and shape future resources.

Bronchiectasis is more common in women and older adults, and in 40% of cases, the underlying cause is unknown. Treatment often includes airway clearance techniques, inhaled medications, antibiotics to manage infections, and in some cases, oxygen therapy. Though the disease shares some symptoms with COPD, it is a distinct condition and must be treated as such—especially for those living with both diseases.

To learn more about bronchiectasis and access educational materials, visit Lung.org/bronchiectasis.

Support for this awareness campaign is provided by Boehringer Ingelheim.

About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, a holder of the coveted 4-star rating from Charity Navigator and a Platinum-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.

CONTACT: Jill Dale | American Lung Association
               P: 312-940-7001 C: 720-438-8289 E: [email protected]

SOURCE American Lung Association